WIXOM, Mich.--(BUSINESS WIRE)--Velesco Pharma, the expert in pharmaceutical development and clinical manufacturing, has expanded and enhanced its formulation and analytical research and development capabilities with the acquisition of a new facility in Wixom, Mich. The acquisition and fit-out of this new facility doubles Velesco Pharma’s formulation and analytical laboratory space and allows the company to maintain the impressive growth rate experienced in recent years. This capital investment and increase in capacity promotes expansion of services to more fully meet the needs of its broad client base.
Velesco Pharma will continue to offer both research and cGMP services including formulation development, analytical method development/validation, release and stability testing and cGMP clinical manufacturing. The move of Velesco Pharma’s laboratories to the expanded facility will occur before the end of the year.
“Our new laboratory is impressively designed and equipped, and we will be increasing our scientific team such that we can meet our clients’ growing demand for pharmaceutical formulation and analytical services,” said Dave Barnes, Ph.D., chief executive officer at Velesco. “We look forward to opening the doors of our new center of excellence and collaborating with our current and new clients to ensure the quality and responsiveness their drug development programs demand.”
About Velesco Pharmaceutical Services
Velesco
Pharma was formed by former big pharma R&D colleagues and focuses on
supporting early and later stage drug development. Velesco provides fast
and cost-effective contract analytical development and drug formulation
services along with cGMP clinical supplies offering a full range of
non-sterile dosage forms. The team offers personalized project
management, state-of-the-art facilities and an experienced laboratory
staff leading to comprehensive research relationships. Please visit
Velesco’s leadership team at Booth #2415 at AAPS PharmSci 360 in
Washington, D.C. on November 4-7.
